It has been suggested that upregulation of GDF-15 occurs in response to inflammation that precedes diabetes, but that this upregulation is not sufficient to compensate for the chronic low-grade inflammation [31], which leads to metabolic disorders such as β cell dysfunction and insulin resistance [31, 32]. This evidence concerns the gene GDF15 and Insulin resistance.